Terms: = Thyroid cancer AND PAX8, ENSG00000125618, 7849 AND Staging
5 results:
1. [ANAPLASTIC TRANSFORMATION OF METASTATIC PAPILLARY thyroid CARCINOMA IN A CERVICAL LYMPH NODE - A TIMELINE].
Horev Y; Vaknine H; Cinamon U
Harefuah; 2020 Nov; 159(11):809-814. PubMed ID: 33210851
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate thyroid Nodules.
Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
[No Abstract] [Full Text] [Related]
3. Molecular Markers Involved in Tumorigenesis of thyroid Carcinoma: Focus on Aggressive Histotypes.
Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
[TBL] [Abstract] [Full Text] [Related]
4. ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.
Tavares C; Melo M; Cameselle-Teijeiro JM; Soares P; Sobrinho-Simões M
Eur J Endocrinol; 2016 Apr; 174(4):R117-26. PubMed ID: 26510840
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic markers and prognostic factors in thyroid cancer.
Vriens MR; Schreinemakers JM; Suh I; Guerrero MA; Clark OH
Future Oncol; 2009 Oct; 5(8):1283-93. PubMed ID: 19852742
[TBL] [Abstract] [Full Text] [Related]
